156 related articles for article (PubMed ID: 7635013)
1. European Medicines Evaluation Agency and the new licensing arrangements.
Drug Ther Bull; 1994 Dec; 32(12):89-90. PubMed ID: 7635013
[TBL] [Abstract][Full Text] [Related]
2. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
3. The licensing of medicines in the UK.
Drug Ther Bull; 2009 Apr; 47(4):45-8. PubMed ID: 19357299
[TBL] [Abstract][Full Text] [Related]
4. EMEA (European Medicines Evaluation Agency) and the new pharmaceutical procedures for Europe.
Jones K; Jefferys D
Health Trends; 1994; 26(1):10-3. PubMed ID: 10171959
[TBL] [Abstract][Full Text] [Related]
5. [Europe and medicines: role of the EMEA].
Sauer F
Ann Pharm Fr; 2000 Jul; 58(4):278-85. PubMed ID: 10915977
[TBL] [Abstract][Full Text] [Related]
6. [The regulatory framework for complementary and alternative medicines in Europe].
Knöss W; Stolte F; Reh K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
[TBL] [Abstract][Full Text] [Related]
7. Overview of the European regulatory approval system.
Pignatti F; Boone H; Moulon I
J Ambul Care Manage; 2004; 27(2):89-97. PubMed ID: 15069985
[TBL] [Abstract][Full Text] [Related]
8. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
Tomić S; Sucić AF; Martinac AI
Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
[TBL] [Abstract][Full Text] [Related]
9. [European Agency for the Evaluation of Medicinal Products: five years experience].
Sauer F
Bull Mem Acad R Med Belg; 2000; 155(5-6):254-8; discussion 259-62. PubMed ID: 11304960
[TBL] [Abstract][Full Text] [Related]
10. [Scientific advice by the nationally competent authority and by the EMEA on the conduct of clinical trials].
Dejas-Eckertz P; Schäffner G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):423-8. PubMed ID: 15830253
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials for registration in the European Union: the EMEA 5-year experience in oncology.
Pignatti F; Aronsson B; Vamvakas S; Wade G; Papadouli I; Papaluca M; Moulon I; Le Courtois P
Crit Rev Oncol Hematol; 2002 May; 42(2):123-35. PubMed ID: 12007970
[TBL] [Abstract][Full Text] [Related]
12. EMEA and the new pharmaceutical procedures for Europe. European Medicines Evaluation Agency.
Jefferys DB; Jones KH
Eur J Clin Pharmacol; 1995; 47(6):471-6. PubMed ID: 7768246
[TBL] [Abstract][Full Text] [Related]
13. Licensing new antibacterial agents - a European perspective.
Powell M
Int J Antimicrob Agents; 2000 Nov; 16(3):199-203. PubMed ID: 11091036
[TBL] [Abstract][Full Text] [Related]
14. A critique to the European regulatory system.
Bertele' V; Li Bassi L
J Ambul Care Manage; 2004; 27(2):98-104. PubMed ID: 15069986
[TBL] [Abstract][Full Text] [Related]
15. Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance.
Permanand G; Mossialos E; McKee M
Clin Med (Lond); 2006; 6(1):87-90. PubMed ID: 16521363
[TBL] [Abstract][Full Text] [Related]
16. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
Ainsworth MA
Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
[TBL] [Abstract][Full Text] [Related]
17. Regulatory policies on medicines for psychiatric disorders: is Europe on target?
Barbui C; Garattini S
Br J Psychiatry; 2007 Feb; 190():91-3. PubMed ID: 17267922
[TBL] [Abstract][Full Text] [Related]
18. [The role of the Committee for Medicinal Products for Human Use (CHMP) in the European centralised procedure].
Enzmann H; Schneider C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):731-9. PubMed ID: 18584106
[TBL] [Abstract][Full Text] [Related]
19. [National and European drug approval procedures].
Mohrbutter KP
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):593-6. PubMed ID: 9527447
[TBL] [Abstract][Full Text] [Related]
20. Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use.
Impicciatore P; Choonara I
Br J Clin Pharmacol; 1999 Jul; 48(1):15-8. PubMed ID: 10383554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
